Transgene Announces Upcoming Investor Meetings

information fournie par Boursorama CP •14/09/2023 à 17:45

Strasbourg, September 14, 2023 - 05:45 pm CET

TRANSGENE (Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that Management will participate in several investor events, as set out below.

• Cantor Global Healthcare Conference, New York, USA: September 26, 2023
• Investor Access Forum, Paris, France: October 9, 2023
• HealthTech Innovation Days 2023, Paris, France: October 24 & 25, 2023


Next scheduled financial communication
First Half 2023 Financial Results
September 20, 2023, after trading hours – The company will host a conference call at 6:00 pm CET

.../...